For more information or confidential assistance
800-306-3180
se habla español

Laura Woods

Laura is a fierce supporter of informing the public about dangerous drugs and the lawsuits currently pending against their manufacturers.

FDA Invokana Study Finds Potential Amputation Link

FDA
The U.S. Food and Drug Administration has issued a new safety alert regarding the type 2 diabetes drug canagliflozin — Invokana and Invokamet. The Agency issued a safety announcement on May 18, notifying patients and the medical community that results of an ongoing clinical trial revealed a higher number of... Read more »

Xarelto MDL Continues to Grow

The Xarelto multidistrict litigation in Louisiana continues to grow, as another lawsuit was added to the ongoing proceedings on February 11. Estella Roethler filed a lawsuit individually and as the representative of the estate of Augustina Asocar Rodriguez. Rodriguez was prescribed and ingested the blood thinning medication from approximately January... Read more »

Testosterone Claim Involving Testim Joins MDL 2545

Byetta pancreatic cancer patient
An Arlington, Texas man has filed a testosterone lawsuit against Endo Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline, LLC. His lawsuit will join the multidistrict litigation in the Northern District of Illinois. According to his short form complaint, the man was prescribed and began taking Testim in June 2010. In... Read more »

Couple Files Mesothelioma Lawsuit Against Colgate, Pfizer

Courthouse
A Wisconsin couple has filed a lawsuit against the Colgate-Palmolive Company, Pfizer and a number of affiliates, claiming asbestos in some of the companies’ talc products caused the husband to develop mesothelioma. From approximately 1967 through the 1970’s, Steven P. Schultz’s mother used the asbestos-containing Cashmere Bouquet Talcum Powder products... Read more »

New Report Warns of 21st Century Cures Act Shortfalls

drugreporter.com
In December 2015, non-profit group Public Citizen published a report highlighting a provision in the proposed 21st Century Cures Act that could cost taxpayers $12 billion — and that’s just one of the expenses. The report — written by Sammy Almashat and Sarah Sorscher of Public Citizen’s Health Research Group... Read more »

January Status Conference Set for NJ Talc MCL

Courthouse
A January status conference has been scheduled to discuss the next steps in the talcum powder lawsuits currently pending in New Jersey state court. Judges Julio L. Mendez and Nelson C. Johnson of Atlantic County are expected to review the organizational structure of the multicounty litigation and provide status updates... Read more »

Status Conference Scheduled for GranuFlo, NaturaLyte MDL

The parties involved in the GranuFlo and NaturaLyte multidistrict litigation were scheduled to meet on Friday, Nov. 22. In a status conference before U.S. District Judge Douglas P. Woodlock, both parties were expected to evaluate the proposed start dates for the first two bellwether trials, to see if they’re on-track. The... Read more »

Maryland Man Receives $1.75 Million Risperdal Verdict

A Philadelphia jury has ordered Janssen Pharmaceuticals — a Johnson & Johnson subsidiary — to pay $1.8 million to a man who developed breasts while taking the pharmaceutical giant’s antipsychotic drug Risperdal. Jurors determined that the company knew the prescription medication could trigger atypical breast growth, but failed to properly... Read more »

Louisiana Mother Blames Zofran for Son’s Heart Condition

A Louisiana mother has filed a Zofran lawsuit against GlaxoSmithKline on behalf of her son. Zofran (ondansetron) is a prescription medication used to prevent nausea and vomiting in chemotherapy or radiation patients. It is also commonly used by pregnant women suffering from morning sickness, though it has not received approval... Read more »